Richard Ghalie

Chief Tech/Sci/R&D Officer presso MEI PHARMA, INC.

Patrimonio netto: 5 784 $ in data 31/03/2024

66 anni

100 relazioni

Health Technology

Consumer Services

Health Services

Posizioni attive di Richard Ghalie

Società	Posizione	Inizio	Fine
MEI PHARMA, INC.	Chief Tech/Sci/R&D Officer	01/03/2016	-
Viracta Subsidiary, Inc. Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA.	Director/Board Member	01/06/2015	-

Storia della carriera di Richard Ghalie

Precedenti posizioni note di Richard Ghalie

Società	Posizione	Inizio	Fine
Favrille, Inc.	Chief Tech/Sci/R&D Officer	01/05/2007	22/04/2009
LIGAND PHARMACEUTICALS INCORPORATED	Chief Tech/Sci/R&D Officer	01/01/2003	01/01/2007
PONIARD PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	01/01/2001	01/01/2003
PONIARD PHARMACEUTICALS, INC.	General Counsel	01/01/2001	01/01/2003
Immunex Corp. Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation	Corporate Officer/Principal	01/01/1994	01/01/2001
Denovo Biopharma LLC Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA.	Chief Tech/Sci/R&D Officer	-	-
Rush University Medical Center Rush University Medical Center Medical/Nursing ServicesHealth Services Rush University Medical Center engages in the provision of health care services. The company was founded in 1972 and is headquartered in Chicago, IL.	Corporate Officer/Principal	-	-
Novalar Pharmaceuticals, Inc. Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA.	Chief Tech/Sci/R&D Officer	-	-
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░ ░░░░░░░░░░░░ ░░░░░░░	░░░░░░░░░░	-

Formazione di Richard Ghalie

University of Washington	Masters Business Admin
St. Joseph's College	Doctorate Degree

Statistiche

Distribuzione geografica

Stati Uniti	12
India	2
Francia	2

Posizioni

Chief Tech/Sci/R&D Officer	7
Corporate Officer/Principal	2
General Counsel	1

Settori

Health Technology	10
Consumer Services	4
Health Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società collegate

Società quotate in Borsa	3
PONIARD PHARMACEUTICALS, INC.	Health Technology
LIGAND PHARMACEUTICALS INCORPORATED	Health Technology
MEI PHARMA, INC.	Health Technology

Aziende private	8
Immunex Corp. Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation	Health Technology
Favrille, Inc.	Health Technology
Novalar Pharmaceuticals, Inc. Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA.	Health Technology
Université Paris Diderot-Paris 7	Consumer Services
Rush University Medical Center Rush University Medical Center Medical/Nursing ServicesHealth Services Rush University Medical Center engages in the provision of health care services. The company was founded in 1972 and is headquartered in Chicago, IL.	Health Services
HemaQuest Pharmaceuticals, Inc. HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA.	Health Technology
Denovo Biopharma LLC Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA.	Health Technology
Viracta Subsidiary, Inc. Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA.	Health Technology

Vedi le connessioni aziendali